Please login to the form below

Tredaptive

This page shows the latest Tredaptive news and features for those working in and with pharma, biotech and healthcare.

this year after disappointments such as the failure of cholesterol drug Tredaptive (extended-release niacin/laropiprant).

Merck & Co inches closer to US green light for insomnia drug

The company suffered another R&D setback recently when it dropped development of another phase III project – cardiovascular treatment Tredaptive ER (laropiprant and niacin) – after disappointing results in the HPS-2
Merck cuts outlook as Q1 sales fall

including the failure of cholesterol drug Tredaptive (extended-release niacin/laropiprant). .
Former Amgen R&D head Perlmutter to lead research at Merck & Co

The company recently dropped cholesterol drug Tredaptive (extended-release niacin/laropiprant) after disappointing results in a trial, which showed it was no more effective than statins but increased the risk of
MHRA plays catch up with pharma on Twitter

But the use of new, separate accounts for medicines and medical devices seems logical, given the differences in audience for a recall of Merck Sharp &Dohme's Tredaptive versus that for
EMA recommends suspension of Merck's Tredaptive

The EMA's confirmation now seals Tredaptive's fate, and the regulator recommended patients taking the medicine should make a non-urgent appointment with their doctor to discuss treatment options. ... Outside Europe, Merck has already said it does not

More from news
Approximately 3 fully matching, plus 9 partially matching documents found.

Closing the treatment gap

This included a global release available at the press event and distribution over the wires, a glossy media guide to cardiovascular disease, fact sheets on heart disease, Merck’s drug Tredaptive

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

PR/ PA Account Executive (UK Healthcare Industry specialist, cam...: Competitive

Account Supervisor – Leading Healthcare Advertising Agency – New...: Highly Competitive Salary, Bonus &Benefits

Vaccines writer – career opportunity to move into medcomms from ...: Highly competitive salary

Client Services Director, MRNA/ Covid 19, Medical Communications...: Highly competitive salary

Senior Medical Writer – Creative Healthcare Advertising – New Yo...: Highly Competitive Salary, Bonus &Benefits

Scientific Director, MRNA/ Covid 19, Medical Communications, UK: Six figure salary

Medical Writers > Scientific Directors – Medical Communicatio...: Highly Competitive Salary, Bonus &Benefits

Senior Account Exec > CSD – Medical Communications – UK, Lond...: Highly Competitive Salary, Bonus &Benefits

HR Manager – Recruitment/ Generalist combined role, Marketing ag...: circa £50K

Principal Medical Writer, MRNA/ Covid 19, Medical Communications...: Highly competitive salary

Add my company

Cegedim Health Data provides Real World Data and Evidence services to enable advancements in patient outcomes. With a data history...

What does the future hold for Light-chain Amyloidosis?: Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:: Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs): How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...

Email:
Password: